Actively Recruiting

Phase 3
Age: 18Years - 75Years
All Genders
NCT07043725

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Led by Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Updated on 2026-03-27

544

Participants Needed

78

Research Sites

206 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a randomized, open, positive drug control, multi center phase III study. Through the evaluation of tpCR, bpCR, ORR, EFS, IDFS, OS , AEs and other indicators, it proves the effectiveness and safety of TQB2102 for injection versus TCbHP in the neoadjuvant treatment of HER2 positive breast cancer patients.

CONDITIONS

Official Title

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Voluntarily agree to participate and sign informed consent with good compliance
  • Eastern Cooperative Oncology Group performance status (ECOG PS) score of 0 or 1 with expected survival over 6 months
  • Histologically or cytologically confirmed HER2-positive invasive breast cancer
  • Confirmed hormone receptor (HR) status
  • Clinical stage T2-4 with any N, M0; or any T with N1-3, M0
  • Agree to undergo breast cancer surgery if eligible after neoadjuvant therapy
  • Adequate major organ function meeting study criteria
  • Agree to use contraception during the study and for 6 months after; female patients must have a negative serum pregnancy test within 7 days before enrollment and not be lactating; male patients must agree to contraception use
Not Eligible

You will not qualify if you...

  • Stage IV metastatic breast cancer or judged unsuitable for surgical resection after neoadjuvant therapy
  • Bilateral breast cancer or inflammatory breast cancer
  • History of invasive breast cancer or ductal carcinoma in situ
  • Prior anti-tumor therapy for breast cancer including chemotherapy, endocrine therapy, targeted therapy, radiotherapy, surgery
  • Other malignancies within 5 years or currently
  • Unresolved adverse reactions from prior treatment above CTCAE grade 1
  • Major surgery, significant trauma, or unhealed wounds/fractures within 4 weeks before first dose
  • Conditions affecting intravenous injection or blood sampling
  • Congenital bleeding or coagulation disorders or recent use of certain blood-thinning medications
  • Recent arterial or deep venous thrombotic events within 6 months
  • Poorly controlled high blood pressure
  • Significant cardiovascular disease
  • Uncontrolled infection of grade 2 or higher within 14 days before study treatment
  • History or current interstitial lung disease or pneumonitis requiring steroid treatment
  • Prior excisional biopsy or sentinel lymph node biopsy before study treatment
  • Anti-tumor therapy within 3 weeks before study treatment
  • Prior taxane or carboplatin therapy for any cancer
  • Use of traditional Chinese medicine with anti-tumor effects within 2 weeks before treatment
  • Severe allergy to monoclonal antibodies or study drugs
  • Uncontrolled active autoimmune disease within 2 weeks before treatment
  • Live vaccinations within 28 days before study treatment
  • Any condition that may risk safety or study completion as judged by investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 78 locations

1

The First Affiliated Hospital of Bengbu Medical University

Bengbu, Anhui, China, 233000

Not Yet Recruiting

2

Anhui Provincial Cancer Hospital

Hefei, Anhui, China, 230000

Not Yet Recruiting

3

The First Affiliated Hospital of Wannan Medical University

Wuhu, Anhui, China, 241000

Not Yet Recruiting

4

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China, 100005

Not Yet Recruiting

5

Beijing Cancer Hospital

Beijing, Beijing Municipality, China, 100142

Not Yet Recruiting

6

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400010

Not Yet Recruiting

7

The Second Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400010

Not Yet Recruiting

8

The Cancer Hospital Affiliated to Chongqing University, Chongqing Cancer Hospital, Chongqing Cancer Research Institute, and Chongqing Cancer Center

Chongqing, Chongqing Municipality, China, 400030

Not Yet Recruiting

9

The First Hospital Affiliated to Army Medical University

Chongqing, Chongqing Municipality, China, 400038

Not Yet Recruiting

10

Quanzhou First Hospital

Quanzhou, Fujian, China, 362000

Not Yet Recruiting

11

The Second Affiliated Hospital of Fujian Medical University

Quanzhou, Fujian, China, 362000

Not Yet Recruiting

12

Zhongshan Hospital Xiamen university

Xiamen, Fujian, China, 361006

Not Yet Recruiting

13

ZhangZhou Municipal Hospital of Fujian Province

Zhangzhou, Fujian, China, 363099

Not Yet Recruiting

14

The First Hospital of Lanzhou University

Lanzhou, Gansu, China, 730000

Not Yet Recruiting

15

Gansu Provincial Academic Institute for Medical Research, Gansu Provincial Cancer Hospital

Lanzhou, Gansu, China, 730050

Not Yet Recruiting

16

Gansu Wuwei Tumour Hospital

Wuwei, Gansu, China, 730000

Not Yet Recruiting

17

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China, 510000

Not Yet Recruiting

18

The Second Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China, 510000

Not Yet Recruiting

19

Meizhou People's Hospital

Meizhou, Guangdong, China, 514000

Not Yet Recruiting

20

Shantou Central Hospital

Shantou, Guangdong, China, 515031

Not Yet Recruiting

21

Guigang City People's Hospital

Guigang, Guangxi, China, 537300

Not Yet Recruiting

22

Guangxi Cancer Institutu (Guangxi Cancer Hospital, Guangxi Medical University Cancer Hospital, Guangxi Cancer Center)

Nanning, Guangxi, China, 530021

Not Yet Recruiting

23

The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China, 530022

Not Yet Recruiting

24

The Affiliated Cancer Hospital of Guizhou Medical University

Guiyang, Guizhou, China, 550001

Not Yet Recruiting

25

Guizhou Provincial People's Hospital

Guiyang, Guizhou, China, 550002

Not Yet Recruiting

26

Cangzhou Central Hospital

Cangzhou, Hebei, China, 061012

Not Yet Recruiting

27

First Hospital of QinHuangDao

Qinhuangdao, Hebei, China, 066099

Not Yet Recruiting

28

The Fourth Hospital of Hebei Medical University

Shijiazhuang, Hebei, China, 050035

Not Yet Recruiting

29

Jiamusi Cancer Hospital

Jiamusi, Heilongjiang, China, 154002

Actively Recruiting

30

Harbin Medical University Cancer Hospital

Harbin, Heilongjinag, China, 150081

Not Yet Recruiting

31

Anyang Tumor Hospital

Anyang, Henan, China, 455001

Not Yet Recruiting

32

The People's Hospital of Anyang City

Anyang, Henan, China, 455099

Not Yet Recruiting

33

The First Affiliated Hospital of Henan University of Science and Technology

Luoyang, Henan, China, 471000

Not Yet Recruiting

34

The First Affiliated Hospital of Xinxiang Medical University

Xinxiang, Henan, China, 453100

Not Yet Recruiting

35

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China, 453000

Not Yet Recruiting

36

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430000

Not Yet Recruiting

37

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China, 430000

Not Yet Recruiting

38

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China, 410011

Not Yet Recruiting

39

Xiangya Hospital Central South University

Changsha, Hunan, China, 410028

Not Yet Recruiting

40

The First Affiliated Hospital of University of South China

Hengyang, Hunan, China, 421200

Not Yet Recruiting

41

Xiangya Hospital ZhuZhou Central South University

Zhuzhou, Hunan, China, 412007

Not Yet Recruiting

42

Chifeng Municipal Hospital

Chifeng, Inner Mongolia, China, 24000

Not Yet Recruiting

43

Jiangsu Province Hospital

Nanjing, Jiangsu, China, 210029

Not Yet Recruiting

44

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China, 210031

Not Yet Recruiting

45

NanChang People's Hospital

Nanchang, Jiangxi, China, 330009

Not Yet Recruiting

46

Jiangxi Cancer Hospital

Nanchang, Jiangxi, China, 330029

Not Yet Recruiting

47

The First Bethune Hospital of Jilin University

Changchun, Jilin, China, 130000

Not Yet Recruiting

48

The First Affiliated Hospital of Jinzhou Medical University

Jinzhou, Liaoning, China, 121012

Not Yet Recruiting

49

Shengjing Hospital Of China Medical University

Shenyang, Liaoning, China, 110000

Not Yet Recruiting

50

The First Affiliated Hospital of China Medical University

Shenyang, Liaoning, China, 110002

Not Yet Recruiting

51

Liaoning Cancer Hospital & Institute

Shenyang, Liaoning, China, 111000

Not Yet Recruiting

52

The First Affiliated Hospital of the Air Force Medical University of the People's Liberation Army

Xi'an, Shaanxi, China, 710005

Not Yet Recruiting

53

The Second Affiliated Hospital of the Air Force Medical University of the People's Liberation Army

Xi'an, Shaanxi, China, 710038

Not Yet Recruiting

54

The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China, 710061

Not Yet Recruiting

55

Cancer Hospital of Shandong First Medical University, Shandong Cancer Institute, Shandong Cancer Hospital

Jinan, Shandong, China, 250117

Actively Recruiting

56

Linyi Cancer Hospital

Linyi, Shandong, China, 276034

Not Yet Recruiting

57

The Second Affiliated Hospital of Shandong First Medical University

Taian, Shandong, China, 271000

Not Yet Recruiting

58

WeiFang People's Hospital

Weifang, Shandong, China, 261000

Not Yet Recruiting

59

Weihai Municipal Hospital

Weihai, Shandong, China, 264299

Not Yet Recruiting

60

Yantai Yuhuangding Hospital

Yantai, Shandong, China, 264000

Not Yet Recruiting

61

Zibo Central Hospital

Zibo, Shandong, China

Not Yet Recruiting

62

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China, 200030

Actively Recruiting

63

Huashan Hospital Fudan University

Shanghai, Shanghai Municipality, China, 200052

Not Yet Recruiting

64

Shanxi Cancer Hospital

Taiyuan, Shanxi, China, 030000

Not Yet Recruiting

65

First Hospital of Shanxi Medical University

Taiyuan, Shanxi, China, 030001

Not Yet Recruiting

66

Yuncheng Central Hospital

Yuncheng, Shanxi, China, 044099

Not Yet Recruiting

67

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

Chengdu, Sichuan, China, 610031

Not Yet Recruiting

68

The Affiliated Hospital of Southwest Medical University

Luzhou, Sichuan, China, 646000

Not Yet Recruiting

69

The Second People's Hospital of YiBin

Yibin, Sichuan, China, 644000

Not Yet Recruiting

70

Tianjin Cancer Hospital Airport Hospital

Tianjin, Tianjin Municipality, China, 300060

Not Yet Recruiting

71

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China, 300060

Not Yet Recruiting

72

Xinjiang Medical University Cancer Hospital

Ürümqi, Xinjiang, China, 830000

Not Yet Recruiting

73

Xinjiang Medical University Cancer Hospital

Ürümqi, Xinjiang, China, 830000

Not Yet Recruiting

74

Ningbo Medical Center Lihuili Hospital

Ningbo, Zhejiang, China, 315000

Not Yet Recruiting

75

The First Affiliated Hospital of Ningbo University

Ningbo, Zhejiang, China, 315000

Not Yet Recruiting

76

Shaoxing People's Hospital

Shaoxing, Zhejiang, China, 212300

Not Yet Recruiting

77

Taizhou Hospital of Zhejiang Province

Taizhou, Zhejiang, China, 317000

Not Yet Recruiting

78

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China, 325000

Not Yet Recruiting

Loading map...

Research Team

Z

Zhimin Shao, Doctor

CONTACT

C

Caigang Liu, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | DecenTrialz